Cours Innovus Pharmaceuticals Inc OTC Bulletin Board
Actions
US45778V1061
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+55,55% | 816 Md | |
+39,34% | 634 Md | |
-6,83% | 351 Md | |
+17,15% | 323 Md | |
+7,09% | 293 Md | |
+13,26% | 238 Md | |
+0,94% | 222 Md | |
+13,36% | 218 Md | |
+7,87% | 167 Md |